港股異動丨阿里巴巴拉昇漲超9%,蔡崇信確認阿里與蘋果合作
阿里巴巴(9988.HK)進一步拉昇,一度漲超9%,報124.3港元,股價創2022年1月以來新高。消息面上,在阿聯酋迪拜2月13日舉辦的World Governments Summit 2025峯會上,阿里巴巴聯合創始人、董事局主席蔡崇信迴應阿里與蘋果合作傳聞,他表示,蘋果在中國需要一個本地化的合作夥伴,爲他們的手機服務。蘋果一直非常挑剔,他們與中國的多家公司進行了交談。最終,他們選擇與我們做生意。我們非常幸運,也非常榮幸能夠與蘋果這樣的偉大公司做生意。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.